Redox Stimulation of Cardiomyogenesis Versus Inhibition of Vasculogenesis Upon Treatment of Mouse Embryonic Stem Cells with Thalidomide

Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase

(2009) Syamantak Majumder et al.   BRITISH JOURNAL OF PHARMACOLOGY

Thalidomide alters nuclear architecture without ABCB1 gene modulation in drug-resistant myeloma cells

(2009) Trussardi-Regnier   INTERNATIONAL JOURNAL OF ONCOLOGY

Molecular control of blood flow and angiogenesis: role of nitric oxide

(2009) W. C. SESSA   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

(2009) C. Therapontos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Static Electromagnetic Fields Induce Vasculogenesis and Chondro-Osteogenesis of Mouse Embryonic Stem Cells by Reactive Oxygen Species-Mediated Up-Regulation of Vascular Endothelial Growth Factor

(2009) Mohamed M. Bekhite et al.   STEM CELLS AND DEVELOPMENT

A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma

(2008) Lisa K. Hicks et al.   CANCER TREATMENT REVIEWS

Hydrogen Peroxide Decreases Endothelial Nitric Oxide Synthase Promoter Activity through the Inhibition of Sp1 Activity

(2008) Sanjiv Kumar et al.   DNA AND CELL BIOLOGY

Thalidomide: Mechanisms of Action

(2008) Taraneh Paravar et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions

(2008) Ling Lu et al.   MICROVASCULAR RESEARCH

The G-rich promoter and G-rich coding sequence of basic fibroblast growth factor are the targets of thalidomide in glioma

(2008) S.-C. Mei et al.   MOLECULAR CANCER THERAPEUTICS

Thalidomide Resistance Is Based on the Capacity of the Glutathione-Dependent Antioxidant Defense

(2008) Jürgen Knobloch et al.   MOLECULAR PHARMACEUTICS

Combinatorial Antileukemic Disruption of Oxidative Homeostasis and Mitochondrial Stability by the Redox Reactive Thalidomide 2-(2,4-Difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and Flavopiridol

(2008) Y. Ge et al.   MOLECULAR PHARMACOLOGY